Why we are bringing value creation back to Europe in 2026
Establishing a pharmaceutical company at a high-cost location such as Austria sometimes raises questions. From Complex Pharmaceuticals’ perspective, the answer lies in the changed requirements for supply security, quality and technological independence within the European pharmaceutical industry. Recent years have clearly demonstrated how deeply interconnected global supply chains are, and how important robust, regionally anchored…